Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.840
+0.140 (8.24%)
At close: Oct 2, 2025, 4:00 PM EDT
1.880
+0.040 (2.17%)
After-hours: Oct 2, 2025, 7:51 PM EDT
Propanc Biopharma Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|
Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
---|
| 57.05 | 1.29 | 1.53 | 1.73 | 1.58 | |
| 0.22 | 0.25 | 0.25 | 0.26 | 0.23 | |
| 57.28 | 1.54 | 1.78 | 1.99 | 1.81 | |
| -57.28 | -1.54 | -1.78 | -1.99 | -1.81 | |
| -0.56 | -0.67 | -0.53 | -0.57 | -0.45 | |
Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0 | |
Currency Exchange Gain (Loss) | -0.09 | 0.02 | 0.01 | -0.04 | 0.03 | |
Other Non Operating Income (Expenses) | -0.12 | 0.18 | -0.53 | -0.1 | -0.01 | |
EBT Excluding Unusual Items | -58.05 | -2 | -2.83 | -2.7 | -2.24 | |
| -0.87 | 0.05 | 0.04 | -0.02 | 0.1 | |
| -58.92 | -1.95 | -2.79 | -2.71 | -2.14 | |
| - | -0.13 | -0.13 | -0.05 | -0.11 | |
| -58.92 | -1.82 | -2.66 | -2.66 | -2.03 | |
Preferred Dividends & Other Adjustments | - | 0.19 | 0.47 | 0.7 | 0.39 | |
| -58.92 | -2.01 | -3.13 | -3.36 | -2.42 | |
Shares Outstanding (Basic) | 4 | - | - | - | - | |
Shares Outstanding (Diluted) | 4 | - | - | - | - | |
| -14.85 | - | - | - | - | |
| -14.85 | - | - | - | - | |
| -0.41 | -0.94 | -1.11 | -1.44 | -1.15 | |
| -0.10 | - | - | - | - | |
| -57.28 | -1.54 | -1.77 | -1.99 | -1.81 | |
| 0 | 0 | 0 | 0 | 0 | |
| -57.28 | -1.54 | -1.78 | -1.99 | -1.81 | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.